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ESSENTIALS
 Definitions for pulmonary embolism (PE)-related death vary widely.
 A cross-sectional survey on a standardized definition for PE-related death was 
performed.
 Acceptance of the proposed definition by the 40 thrombosis expert respondents was 
excellent.
 Suggestions for improvement were integrated in the final SSC definition of PE-related 
death.
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ABSTRACT
Introduction: Pulmonary embolism (PE)-related death is often part of the primary outcome 
in venous thromboembolism (VTE) studies. The Scientific and Standardization Committee 
(SSC) of the International Society on Thrombosis and Haemostasis developed a definition 
for PE-related death and classification of the cause of death. The present survey evaluated 
a preliminary version of this definition and classification.
Methods: Sixty-nine VTE experts from 9 countries were invited for a cross-sectional online 
survey on January 15th, 2019, including multiple-choice and open-ended questions on a 
seven-subcategory classification of the cause of death. Descriptive statistics were used to 
describe the results; qualitative comments were summarized.
Results: Forty of 69 (58%) invitees completed the survey. All respondents agreed that 
guidance on classification of the cause of death in VTE studies is required. There was high 
agreement on the proposal (median overall score, 6; interquartile range, 6-7; scale from 1 
[poor] to 7 [excellent]). All respondents approved the wording and content of the seven 
subcategories, except for 1 disagreeing vote for 2 subcategories (A3: ‘PE is not objectively 
confirmed, but is most likely the main cause of death’, and C1: ‘Another cause of death is 
more likely than PE but has not been objectively confirmed’). Suggestions for improvement 
mainly concerned the extensiveness of the criteria and clinical situations described to define 
the cause of death.
Conclusion: Acceptance of the proposal was excellent. Suggestions for improvement were 
incorporated in the SSC communication on the definition of PE-related death and 
classification of the cause of death in VTE studies.
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INTRODUCTION
Pulmonary embolism (PE) is a potentially fatal disease. As such, most venous 
thromboembolism (VTE) studies include PE-related death as part of their primary efficacy 
outcome (recurrent) VTE. However, in the absence of a standardized definition for PE-
related death, current definitions for this outcome are heterogeneous and underreported [1]. 
The lack of standardization and reporting hinders comparison of study results and may 
hamper appraisal of the internal and external study validity.
In the current issue of the Journal of Thrombosis and Haemostasis, the International 
Society on Thrombosis and Haemostasis (ISTH) Scientific and Standardization Committee 
(SSC) on Predictive and Diagnostic Variables in Thrombotic Disease proposes a 
standardized definition for PE-related death and classification of the cause of death in 
clinical studies in the field of VTE (ref SSC communication). The definition was developed 
based on a systematic review of definitions for PE-related death used in recent VTE studies 
[1], and two subsequent surveys with VTE experts. The first was a real-time survey to seek 
feedback on a preliminary version of the definition at the 64th SSC Meeting of the ISTH in 
Dublin, Ireland in July 2018. The second survey, a web-based questionnaire, included a 
further developed definition for PE-related death and a classification for the cause of death 
in clinical VTE studies. The detailed results of this survey are presented here.
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METHODS
An online survey was developed on a preliminary version of the definition for PE-related 
death and classification of the cause of death in VTE research. Preceding the invitation, the 
survey was pilot-tested by general internists and thrombosis specialists to minimize 
misinterpretation of questions and to ensure face validity and content validity. The survey 
included three main categories (A: ‘PE-related death’, B: ‘undetermined cause of death’, and 
C: ‘cause of death other than PE’), consisting of seven subcategories to classify the cause of 
death (Table 1). Multiple-choice questions including a 5-point Likert scale were used to 
assess agreement regarding the wording and content of each of the proposed categories of 
the definition. Suggestions for improvement of each category as free text was optional. 
Additionally, respondents were asked which subcategories should be considered for the 
primary analysis and potential sensitivity analyses of the outcome PE-related death. The 
overall rating of the proposed definition was also assessed. Respondents were able to 
adjust given answers at any time before completion of the survey. No adaptive questioning 
was used. The objective of the study, the length of the survey, and the investigators 
conducting the study were described in an invitation letter, which included a web-link to the 
survey. Participation was voluntary and no consent was obtained, other than agreement to 
participate. There were no incentives for participation. SurveyMonkey (SurveyMonkey Inc.; 
San Mateo, California, USA; www.surveymonkey.com) was used to design, distribute, 
conduct, and analyze the survey. Data were stored on a personal account on SurveyMonkey. 
The invitation email was sent to 69 VTE experts from 9 countries on January 15th, 
2019. Two reminders were sent at 3-week intervals to those who did not complete the 
survey, and the survey was closed on March 18th, 2019. Invitees included key opinion 
leaders of the International Network of VENous Thromboembolism Clinical Research 
Networks (INVENT) and event adjudication committee members of recent randomized 
controlled trials with PE-related death as a component of the primary outcome which were 
identified in a systematic review of definitions for PE-related death in recent VTE studies [1].
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Descriptive statistics were used to describe agreement for each subcategory. 
Proportions were calculated on the basis of the total number of respondents per question. 
Qualitative comments were summarized for all the subcategories.
This study adheres to reporting guidelines of survey research [2-4].
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RESULTS AND DISCUSSION
Forty out of 69 (58%) invited VTE experts completed the survey. Respondents were from 9 
different countries (Canada, the United States, the Netherlands, France, Switzerland, Italy, 
Germany, Norway, and Australia), and represented a diverse cohort of experienced 
researchers and clinicians trained in general internal medicine, hematology, pulmonology, 
vascular medicine, radiology, emergency medicine, intensive care medicine, and cardiology. 
Thirteen out of 16 multiple-choice questions were answered by all respondents; the 
remaining multiple-choice questions were answered by all but one respondent (98%). Per 
subcategory, 8 to 18 respondents suggested improvement of wording and content as free 
text.
All respondents agreed that guidance on adjudication of the cause of death in VTE 
studies, especially ‘VTE-related death’ or ‘fatal PE’, is required (87.5% strongly agreed, 12.5% 
agreed). All respondents approved the wording and content of the seven subcategories, 
except for 1 disagreeing vote for 2 subcategories (A3: ‘PE is not objectively confirmed, but is 
most likely the main cause of death’, and C1: ‘Another cause of death is more likely than PE 
but has not been objectively confirmed’) (Table 2). Most respondents (n=23; 58%) preferred 
to include subcategories A1, A2, and A3 (i.e., ‘autopsy-confirmed PE in the absence of 
another more likely cause of death’, ‘objectively confirmed PE before death without a more 
obvious cause of death, and ‘PE is not objectively confirmed, but is most likely the main 
cause of death’) in the primary analysis of PE-related death (Figure 1), and 13 (33%) 
preferred to include only objectively confirmed PE (i.e., subcategories A1 and A2). The 
remaining 4 (10%) respondents preferred to include cases with an undetermined cause of 
death as well (subcategory B1 [i.e., cause of death is undetermined] or subcategories B1 
and B2 [i.e., insufficient clinical information to determine the cause of death]). The vast 
majority (18 of 22; 81%) of the respondents who selected all 3 subcategories of category A 
(‘PE-related death’;  A1, A2, and A3) for the primary analysis of PE-related death, suggested 
to include both subcategories of category B (‘undetermined cause of death’; B1 and B2) for 
the sensitivity analysis. On a scale from 1 to 7 (1 being poor, 7 being excellent), the 
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proposed definition for PE-related death and classification for the causes of death received 
an overall median rating of 6 (interquartile range, 6-7).
Based on suggestions from the respondents, the wording of all subcategories has been 
adjusted (Table 1). An additional comment was added to subcategory A1 (i.e., autopsy-
confirmed PE), explaining that judgment is based on the cause of death in the autopsy 
report. If the cause of death is not reported, adjudication is based on the remaining criteria of 
the classification or on the adjudication committee’s judgment regarding the autopsy results 
and available clinical information.
With regard to ‘objectively confirmed PE before death’ (subcategory A2), the majority of 
respondents supported the proposed maximum timeframe of 48 hours between imaging and 
death. It should be acknowledged that a longer timeframe may be more appropriate in 
certain circumstances, which are not limited to hemodynamic stabilization. Therefore, the 
explanation in the footnote of subcategory A2 was rephrased to read: ‘a longer time period 
may apply on a case-by-case basis.’
Questions arose regarding which imaging modalities would allow for objective 
confirmation of PE as this was not defined in the proposed criteria, for example: “What is 
acceptable for "imaging"? Is echocardiography okay?”. The SSC working group suggests 
that imaging modalities directly visualizing the thrombus or ventilation/perfusion scintigraphy 
may be considered but further specification will not be provided as new imaging techniques 
may emerge over time.
Two respondents suggested to exclude the localization of a DVT as part of the criteria 
for objectively confirmed PE in a patient with symptoms of PE. “Simply upper or lower limb 
DVT (no mention of size or proximity).”; “Presence of any kind of venous thrombosis may be 
reason to suspect PE, not just proximal.” While any confirmed DVT before death may be 
important to consider when adjudicating the cause of death, only proximal DVT of the lower 
extremity in a patient with clinical symptoms of PE can be considered a reliable surrogate for 
PE diagnosis [5]. In contrast, detection of distal DVT is not specific enough to confirm PE, 
because 36% of patients with suspected PE and confirmed distal DVT do not have a PE on 
computed tomography pulmonary angiography [6].A
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Several respondents suggested to merge subcategories A2 (i.e., objectively confirmed 
PE before death) and A3 (i.e., PE is not objectively confirmed, but is most likely the main 
cause of death), or subcategories A3 and B1 (i.e., cause of death is undetermined). While 
there is an obvious difference between objective confirmation of PE and suspected PE 
based on symptomatology (i.e., subcategories A2 and A3), the difference between 
subcategories A3 and B1 may be subtle in some cases. However, as a conservative 
approach, patients in whom PE is considered to be the most likely cause of death based on 
clinical signs or symptoms, in the absence of objective confirmation, should also be 
classified as having died from PE and not as ‘undetermined cause of death’ (category B).
Based on the respondents’ suggestions, subcategories C1 (i.e., another cause of death 
is more likely than PE but has not been objectively confirmed) and C2 (i.e., confirmed cause 
of death other than PE) have been merged, as there is little interest and benefit in classifying 
and reporting those subcategories separately in VTE studies. Several respondents 
suggested to provide a list with prevalent causes of death including readily available 
definitions for other causes of death than PE: “I suggest a limited list of other prevalent 
causes of death.”; “There will need to be ready access to accepted criteria for attributing 
cause of death to other causes (e.g., myocardial infarction, stroke, accident, etc.).” Even 
though, such a list would be desirable, relevant causes of death may vary depending on 
study population and developing definitions of other causes of death than PE was beyond 
the scope of this SSC guidance.
Most of the recent large randomized controlled trials included ‘undetermined cause of 
death’ as part of the primary analysis of the outcome ‘PE-related death’ [1]. Because the 
vast majority of unexplained death cases are not related to PE [7-9], this approach may 
falsely increase the number of deaths attributed to PE in both study arms, and thereby dilute 
relative differences in the outcome PE-related death. Therefore, most respondents 
suggested to only include category A (i.e., subcategory A1 [autopsy-confirmed PE], 
subcategory A2 [objectively confirmed PE before death] and subcategory A3 [PE is not 
objectively confirmed, but is most likely the main cause of death]), and exclude cases for 
which the cause of death remains undetermined (subcategories B1 and B2). Only 10% of A
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respondents suggested to include unexplained death (categories B1 and/or B2) as well. 
Surprisingly, one-third of respondents would only include subcategories A1 (i.e., autopsy-
confirmed PE) and A2 (i.e., objectively confirmed PE before death). However, we believe 
that this approach is too exclusive as PE is hardly ever objectively confirmed as a cause of 
death [1]. Based on the suggestion from one respondent, the recommendation for a 
sensitivity analysis on subcategories of the cause of death has been removed from the SSC 
communication because this may not be a general requirement in VTE research and 
sensitivity analyses should be based on study question and design.
This study has potential limitations. First, the design of the survey and the presentation 
of the proposed criteria may have influenced the approval rate of the definition. However, 
answers to open-ended questions were in line with the responses regarding agreement of 
the proposed subcategories in multiple-choice questions, confirming the robustness of the 
results. Second, even though we used objective criteria to identify VTE experts, the selection 
of invitees may have biased the survey results. Finally, we cannot exclude that respondents 
differed from non-respondents. However, the response rate was comparable to previous 
response rates in surveys with physician experts [4].
In conclusion, this cross-sectional survey evaluated the acceptance of a proposed 
standardized definition for PE-related death, and classification of the cause of death with 
VTE experts. Overall, there was high agreement with regard to the proposed definition and 
the classification of causes of death. The majority of respondents agreed with the proposed 
primary analysis which includes only PE-related death, thereby excluding cases for which 
the cause of death is undetermined. Suggestions for improvement were incorporated in the 
SSC communication on the definition of PE-related death and classification of the cause of 
death in clinical VTE studies.
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Table 1. Preliminary and final definition of pulmonary embolism-related death as proposed by the SSC from the ISTH.
Definition and classification as proposed in the survey Revised and final definition endorsed by ISTH SSC 
A) PE-related death A) PE-related death
A1. Autopsy-confirmed PE in the absence of another more likely 
cause of death
Based on judgment of pathologist upon autopsy.
A1. Autopsy-confirmed PE in the absence of another more 
likely cause of death
A2. Objectively confirmed PE before death without a more obvious 
cause of death
This includes the following situations in the last 48 hours* before death:
 PE diagnosed by imaging.
 Objectively confirmed proximal lower limb DVT in patients with 
symptoms of PE.
A2. Objectively confirmed PE before death in the absence of 
another more likely cause of death
Definition of objectively confirmed PE includes ≥1 of the 
following situations in the last 48 hours* before death:
 PE diagnosed by imaging
 Objectively confirmed proximal DVT of the lower extremity 
in patients with clinical signs and symptoms of PE
A3. PE is not objectively confirmed, but is most likely the main cause 
of death
This includes the following situations in the last 48 hours* before death:
 Patients who presented with signs or symptoms of PE or deep vein 
thrombosis without an objectively confirmed PE diagnosis, but 
without another cause of death that is more likely than PE.
 Acute treatment such as thrombolysis given to a patient with 
suspected recurrent PE in the absence of an objective test 
A3. PE is not objectively confirmed, but is most likely the 
main cause of death
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confirming recurrent PE diagnosis.
B) Undetermined cause of death B) Undetermined cause of death
B1. Cause of death is undetermined
This includes patients for which there is clinical information about the 
death circumstances, but without obvious signs or symptoms that 
indicate a specific cause of death.
B1. Cause of death is undetermined, despite available 
information
B2. Insufficient clinical information to determine the cause of death B2. Insufficient clinical information available to determine the 
cause of death
C) Cause of death other than PE C) Cause of death other than PE
C1. Another cause of death is more likely than PE but has not been 
objectively confirmed
This includes patients without a confirmed cause of death who 
presented with signs or symptoms suggestive of a cause of death other 
than PE, or patients who were known to have a severe chronic medical 
condition with limited life expectancy (e.g., severe COPD, severe heart 
failure and metastatic cancer).
C2. Confirmed cause of death other than PE
*Longer time period may apply if hemodynamic stabilization was never 
achieved between diagnosis and death.
*Longer time period may apply on a case-by-case basis.
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Table 2. Agreement of 40 venous thromboembolism experts with regard to wording and 
content of the proposed categories.
Strongly 
agree
Agree Neither 
agree nor 
disagree
Disagree Strongly 
disagree
No 
answer
A1. Autopsy-confirmed PE 30 (75%) 8 (20%) 2 (5%) 0 0 0
A2. Objectively confirmed 
PE before death
19 (47.5%) 17 (42.5%) 4 (10%) 0 0 0
A3. PE not objectively 
confirmed, but most likely 
main cause of death
8 (20%) 25 (62.5%) 6 (15%) 0 1 (2.5%) 0
B1. Cause of death is 
undetermined
16 (40%) 18 (45%) 6 (15%) 0 0 0
B2. Insufficient clinical 
information to determine 
cause of death
17 (43.6%) 19 (48.7%) 3 (7.7%) 0 0 1
C1. Another cause of death 
is more likely than PE but 
not objectively confirmed
16 (51%) 20 (51.3%) 2 (5.1%) 0 1 (2.6%) 1
C2. Confirmed cause of 
death other than PE
20 (50%) 20 (50%) 0 0 0 0
Abbreviation: PE, pulmonary embolism.
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FIGURE LEGEND
Figure 1. Preference for primary analysis of pulmonary embolism-related death among 40 
venous thromboembolism experts
